Drospirenone is marketed under the following brand names: Yasmin, Yasminelle, Yaz, Beyaz, Ocella, Zarah, and Angeliq.
The US FDA warned Bayer against misstating and misrepresenting the benefits and risks of Yaz and Yasmin and recommended that Bayer change the birth controls' labels to reflect the true risks of the drug (FDA warning letter 1, FDA warning letter 2).
Earlier this summer, Health Canada documents revealed that 23 deaths were linked to Yaz and Yasmin. As of June 2013, Yaz and Yasmin have been the subjects of 13 Canadian class action lawsuits
The most common side effects associated with Yaz and Yasmin include blood clotting, deep vein thrombosis, and pulmonary emboli. Bayer has reportedly failed to accept any responsibility for Yaz and Yasmin causing these adverse events, which have been reported by thousands of women who have been taking these drugs. Gallbladder damage and removal have also been reported. To women who have suffered from gallbladder-related adverse effects, Bayer agreed to pay $2000-$3000.
Hundreds of Australian women are also reporting that they have suffered from serious adverse events, including blood clots, strokes, and heart attacks, from Bayer's Yaz and Yasmin and are collectively seeking class action against Bayer. Lawsuits against Bayer for the adverse events associated with Yaz and Yasmin have spread to France, Europe, and Switzerland.
Rxisk.org: View the reported adverse events from Yaz worldwide
Rxisk.org: View the reported adverse events from Yasmin worldwide
DrugRisk Update: Yaz Lawsuits Spread to Europe As Settlements Continue in U.S.
FDA to Review Safety Issues Surrounding Leading Birth Control Pill Yaz
FDA advisers: revise popular birth control labels
2006 FDA approval of Yaz
Aussie Women to Take On Drug Giant
Contraception: Yaz and Yasmin face 23 Felonious Lawsuits
Bayer Canada Birth Control Pills Spark Lawsuits after Deaths
Yaz Lawsuit Settlements
Bayer’s Yaz Pill Backed by Panel Seeking Clarity on RiskBayer Continues Settlements in Yasmin/Yaz Lawsuits
A Birth Control Pill That Promised Too MuchYaz, Yasmin Birth Control Pills Suspected in 23 Deaths
Related Yaz/Yasmin litigation:
Jessica Bagley v. Bayer Corp., et al.
Cathy M. Walton, Plaintiff, v. Bayer Corporation
Ryan Bleecher, et al., v. Bayer Corp., et al. & Josefina Brambila, et al., v. Bayer Corp., et al.
In re Yasmin and Yaz (drospirenone) Marketing, Sales Practices and Products Liability Litigation
Bradish v. Bayer Healthcare Pharmaceuticals Inc., et al.Kerry Sims v. Bayer Corp., et al.
Laforet-Neer v. Bayer Healthcare Pharmaceuticals Inc., et al.